Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
5
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
5
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
biotech
bristol-myers squibb
cancer
eli lilly
merck
abbvie
amgen
astrazeneca
biogen
cancer immunotherapy
cerevel therapeutics
What
drug
5
×
bio
fda
roundup
approved
cancer
companies
decades
new
advanced
alzheimer’s
annual
approval
arguments
arrival
assessed
attention
award
big
biotech
class
commercialized
communities
competitors
conference
data
death
deeper
dems
digital
disease
dna
drugs
epidemic
esmo
europe
fatty
fingerprint
frenzied
genetic
Language
unset
Current search:
drugs
×
drug
×
" seattle top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More